Email
Print
The Auto Injectors Market size is forecast to reach USD 177.13 Billion by 2030, after growing at a CAGR of 15.04% during the forecast period 2024-2030. The rising incidence of chronic conditions such as diabetes, multiple sclerosis, rheumatoid arthritis, and psoriasis, as well as life-threatening allergies (e.g., anaphylaxis), is a major driver for the demand for auto-injectors. These conditions often require regular or emergency injections, making self-injection devices a preferred solution for patients. As the global burden of these diseases increases, the need for convenient, accurate, and easy-to-use drug delivery systems like auto-injectors continues to rise. Advancements in the design and functionality of auto-injectors are another key driver. Innovations such as reusable auto-injectors with multiple doses, needle-free injection systems, and smart auto-injectors are enhancing the usability and appeal of these devices. These improvements make auto-injectors even more convenient and user-friendly, particularly for patients who need regular injections or are dealing with emergencies.
The increased prevalence of chronic conditions such as diabetes, multiple sclerosis, and rheumatoid arthritis is driving the demand for auto-injectors. According to the Centers for Disease Control and Prevention, the United States had 129 million people with at least one major chronic disease by February 2024, with five of the top ten leading causes of death being avoidable and treatable. Over the last two decades, prevalence has risen, with 42.0% having several illnesses. Chronic diseases have a huge impact on the US healthcare system, accounting for 90.0% of the $4.1 trillion spent yearly. According to the International Diabetes Federation Report in December 2021, diabetes affected approximately 537 million adults aged 20 to 79. By 2030, the total number of people with diabetes is expected to reach 643 million; by 2045, it will reach 783 million. Three out of every four adults with diabetes live in a low- or middle-income country. As these diseases often require long-term, frequent treatments, there is a growing demand for convenient and reliable self-administration methods, which is projected to accelerate the expansion of the auto-injector market.
Browse Related Reports:
Injectable Drug Delivery Market Analysis: By Delivery Devices: Conventional Injection Devices Market, Self-Injection Devices Market, Auto Drug Injecting Devices, Pen Injectors, Needle Free Drug Injection Devices, Needle Free Drug Injection Devices, and others; By Drug Formulations: Conventional Drug Delivery Formulations, Novel Drug Delivery Formulation Solutions; By Therapeutic Areas: Auto-Immune Diseases, Hormonal Disorders, Orphan or Rare Diseases, Oncology, Others; By Application: Diabetes, Cardiovascular diseases, Autoimmune diseases, Hormones replacement, Neurology addiction, Respiratory diseases, Others; By Geography: North America, South America, Europe, APAC.
About IndustryARC:
IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet client research needs at a very quick speed with a variety of options for your business.
We look forward to supporting the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.
Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: [email protected]
USA: (+1) 518-282-4727
Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc